Increased renal vascular sensitivity to angiotensin II in hypertension is due to decreased response to prostaglandins

Journal of Hypertension

Volumn 21, Issue 5, 2003, Pages 969-976

  Palmgren, Eva ^a   Widgren, Bengt ^a   Aurell, Mattias ^a   Herlitz, Hans ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin II; Glomerular filtration rate; Hypertension; Indomethacin; Prostaglandins; Renal blood flow

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN; EDETATE CHROMIUM; INDOMETACIN; PROSTAGLANDIN; PROSTANOID; RENIN; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FAMILY HISTORY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CLEARANCE; KIDNEY PLASMA FLOW; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN SYNTHESIS INHIBITION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0038652065     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200305000-00022     Document Type: Article

References (33)

1. Romero JC, Knox FG. Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandin systems. Hypertension 1988; 11:724-736.
2. Ichikawa I, Harris RC. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int 1991; 40:583-596.
3. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15:451-458.
4. Schramek H, Coroneos E, Dunn MJ. Interactions of the vasoconstrictor peptides, angiotensin II and endothelin-1, with vasodilatory prostaglandins. Semin Nephrol 1995; 15:195-204.
5. Arendshorst WJ, Chatziantoniou C, Daniels FH. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int 1990; 38 (suppl 30):92-96.
6. Chatziantoniou C, Ruan X, Arendhorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 1995; 92:2924-2928.
7. 2 receptor-Gs protein interactions in isolated renal resistance arterioles of spontaneously hypertensive rats. Hypertension 1999; 34:1134-1140.
8. Pfaffenberg RS, Thorne MV, Wing AL. Chronic disease in former college students. VII, characteristisc in youth predisposing to hypertension in late years. Am J Epidemiol 1968; 88:25-32.
9. Widgren B, Herlitz H, Hedner T, Berglund G, Wikstrand J, Jonsson O, Andersson OK. Blunted renal sodium excretion during acute saline loading in normotensive men with positive family history of hypertension. Am J Hypertens 1991; 4:570-578.
10. Widgren B, Herlitz H, Aurell M, Berglund G, Wikstrand J, Andersson OK. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens 1992; 5:167-174.
11. Herlitz H, Widgren B, Urbanavicius V, Attvall S, Persson B. Stimulatory, effect of insulin on tubular sodium reabsorption in normotensive subjects with a positive family history of hypertension. Nephrol Dial Transplant 1996; 11:47-54.
12. Wilhelmsen L, Tibblin G, Werkö L. A primary preventive study in Gothenburg, Sweden. Prev Med 1972; 1:153-160.
13. Isaksson B. A simple formula for the mental arithmetic of the human body surface area. Scand J Clin Lab Invest 1958; 10:283-287.
14. Hamberg M. Inhibition of prostaglandin synthesis in man. Biochem Biophys Res Commun 1972, 49:720-726.
15. Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976; 67:299-306.
16. Morton JJ, Webb DJ. Measurement of plasma angiotensin II. Clin Sci (Colch)1985; 68:483-484.
17. Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Hypertension 1983; 5:368-374.
18. 2 interactions in spontaneously hypertensive rats. Hypertension 1993; 22:688-698.
19. Iwai N, Katsuya T, Ishikawa K, Mannami T, Ogata J, Higaki, et al. Human prostacyclin synthase gene and hypertension. The Suita Study. Circulation 1999; 100:2231-2236.
20. Biron P, Mongeau JG. Familial aggregation of blood pressure and its component. Pediatr Clin North Am 1978; 25:29-33.
21. Johnson BC, Karunas TM, Epstein FH. Longitudinal change in blood pressure in individuals, families and social groups. Clin Sci 1973; 45 (suppl 1):S35-S45.
22. Van Hooft IMS, Grobbee DE, Derkx FHM, de Leeuw PW, Schalekamp MA, Hofman A. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991; 324:1305-1311.
23. Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52:584-594.
24. Rettig R, Schmitt B, Pelzl B, Speck T. The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens 1993; 11:883-891.
25. Guidi E, Bianchi G, Rivolta E, Ponticelli C, Quarto di Palo F, Minetti L, Polli E. Hypertension in man with a kidney transplant: role of familial versus other factors. Nephron 1985; 41:14-21.
26. Webb RC, Johnson JC, Vander AJ, Henry JP. Increased vascular sensitivity to angiotensin II in psychosocial hypertensive mice. Hypertension 1983; 5 (suppl I):165-169.
27. Thibault C, Anand-Srivastava MB. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett 1992; 313:160-164.
28. White BH, Sidu A. Increased expression of inhibitory guanine nucleotide binding proreins in membranes from renal proximal tubules, but not brain striata, of the normotensive and spontaneously hypertensive rat. J Hypertens 1996; 14:1281-1285.
29. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Guelfi D, Muiesan ML. Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 1998; 32:305-310.
30. Schiffrin EL, Park J-B, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-1659.
31. Barton M, Luscher TF. Endothelin antagonists for hypertension and renal disease. Curr Opin Nephrol Hypertens 1999; 8:549-556.
32. Kramer HJ, Stinnesbeck B, Klautke G, Kipnowski J, Klingmueller D, Glaenzer K, Duesing R. Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake. Clin Sci 1985; 68:387-393.
33. Fricker AF, Nussberger J, Meilenbrock S, Brunner HR, Burnier M. Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects. Kidney Int 1998; 54:2089-2097.